Metraipolis › archive › dc_2f2ebbaccee2

A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers — Europe PMC PMID:37018347

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/37018347
DOI: 10.1371/journal.pone.0283977
License (as archived): solo-consultazione
Archived: 2026-10-08T05:48:47.552Z
SHA-256 of the archived text: b59196b8b65079c8ac8c924260656d957c590c63c9b02dca3abcfeca2fe4f7fb
Stable URL of this page: https://metraipolis.com/documento/dc_2f2ebbaccee2

How to cite

A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers — Europe PMC PMID:37018347 — Europe PMC (en), https://europepmc.org/article/MED/37018347 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2f2ebbaccee2 (Metraipolis archive dc_2f2ebbaccee2, sha256 b59196b8b65079c8ac8c924260656d957c590c63c9b02dca3abcfeca2fe4f7fb)

BibTeX

@misc{dc2f2ebbaccee2,
  title = {A model for estimating costs and benefits of new vaccine technologies from the perspective of both buyers and sellers — Europe PMC PMID:37018347},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37018347},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2f2ebbaccee2; sha256 b59196b8b65079c8ac8c924260656d957c590c63c9b02dca3abcfeca2fe4f7fb},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37018347. Agents can read the archived copy with the MCP tool read_document.